发明名称 |
USE OF T-CELL IMMUNE RESPONSE CDNA 7 (TIRC7) IN ANGIOGENIC AND ANTI-ANGIOGENIC THERAPY |
摘要 |
A novel use of T-cell immune response cDNA 7 (TIRC7) in angiogenic and anti-angiogenic therapy is described. Provided are agents such as anti-TIRC7 antibodies and methods of treatment which through modulating the activity of TIRC7 can be used for enhancing or suppressing angiogenesis and/or neovascularization, an important feature in many pathological conditions including wound healing, solid tumors, developing metastases, ischemic heart diseases and diabetic retinopathy. Furthermore, diagnostic methods for the detection of such diseases using TIRC7 specific agents are provided. |
申请公布号 |
WO03045420(A2) |
申请公布日期 |
2003.06.05 |
申请号 |
WO2002EP13384 |
申请日期 |
2002.11.27 |
申请人 |
UTKU, NALAN;WARNKE, PETER, CHRISTIAN |
发明人 |
UTKU, NALAN;WARNKE, PETER, CHRISTIAN |
分类号 |
A61K31/7088;A61K38/17;A61K39/395;A61K47/48;A61K48/00;A61P9/00;A61P35/00;C07K14/47;C12Q1/68;G01N33/574;G01N33/68 |
主分类号 |
A61K31/7088 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|